May 08, 2019
Stellar Biotechnologies Reports Second Quarter Financial Results
Mar 08, 2019
Stellar Biotechnologies and Edesa Biotech Sign Share Exchange Agreement
Feb 05, 2019
Stellar Biotechnologies Reports First Quarter Financial Results
Nov 30, 2018
Stellar Biotechnologies Reports Fiscal Year 2018 Financial Results
Oct 31, 2018
Stellar Biotechnologies to Present at BlueTech Summit
Sep 05, 2018
Stellar Biotechnologies to Supply KLH to National Institutes of Health
Aug 28, 2018
Stellar Biotechnologies to Present at H. C. Wainwright Global Investment Conference
Aug 08, 2018
Stellar Biotechnologies Reports Third Quarter Financial Results
Jul 05, 2018
Stellar Issues Statement on Favorable Clinical Study Results
Jun 21, 2018
Stellar Reports Positive Research Results from KLH Glycosylation Study
May 24, 2018
Stellar Biotechnologies Announces Exercise of Warrants Resulting in Cash Proceeds of $3 Million
May 24, 2018
Stellar Achieves Robust Viral Clearance for Manufacturing Process
May 15, 2018
Stellar Biotechnologies Announces Closing of $5.5 Million Public Offering
May 11, 2018
Stellar Biotechnologies Announces Pricing of $5.5 Million Public Offering
May 07, 2018
Stellar Biotechnologies Reports Second Quarter Financial Results
Apr 27, 2018
Stellar Biotechnologies Announces One-for-Seven Reverse Split
Feb 07, 2018
Stellar Biotechnologies Reports First Quarter 2018 Financial Results
Jan 25, 2018
Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors
Dec 01, 2017
Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results
Nov 29, 2017
Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference